These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 14639103
1. DPC4/Smad4: no mutations, rare allelic imbalances, and retained protein expression in pancreatic endocrine tumors. Perren A, Saremaslani P, Schmid S, Bonvin C, Locher T, Roth J, Heitz PU, Komminoth P. Diagn Mol Pathol; 2003 Dec; 12(4):181-6. PubMed ID: 14639103 [Abstract] [Full Text] [Related]
2. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Bartsch D, Hahn SA, Danichevski KD, Ramaswamy A, Bastian D, Galehdari H, Barth P, Schmiegel W, Simon B, Rothmund M. Oncogene; 1999 Apr 08; 18(14):2367-71. PubMed ID: 10327057 [Abstract] [Full Text] [Related]
3. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation. Popović Hadzija M, Radosevic S, Kovacević D, Lukac J, Hadzija M, Spaventi R, Pavelić K, Kapitanović S. Mutat Res; 2004 Apr 14; 548(1-2):61-73. PubMed ID: 15063137 [Abstract] [Full Text] [Related]
4. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients. Koyama M, Ito M, Nagai H, Emi M, Moriyama Y. Mutat Res; 1999 Aug 14; 406(2-4):71-7. PubMed ID: 10479724 [Abstract] [Full Text] [Related]
5. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Moore PS, Orlandini S, Zamboni G, Capelli P, Rigaud G, Falconi M, Bassi C, Lemoine NR, Scarpa A. Br J Cancer; 2001 Jan 14; 84(2):253-62. PubMed ID: 11161385 [Abstract] [Full Text] [Related]
6. The 18q21 region in colorectal and pancreatic cancer: independent loss of DCC and DPC4 expression. Barberá VM, Martín M, Mariñoso L, Munné A, Carrato A, Real FX, Fabre M. Biochim Biophys Acta; 2000 Oct 18; 1502(2):283-96. PubMed ID: 11040453 [Abstract] [Full Text] [Related]
7. [Alterations in DPC4 gene in pancreatic cancers]. Gu L, Chen J, Cui Q. Zhonghua Zhong Liu Za Zhi; 2001 Jul 18; 23(4):293-5. PubMed ID: 11783110 [Abstract] [Full Text] [Related]
8. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. Görtz B, Roth J, Krähenmann A, de Krijger RR, Muletta-Feurer S, Rütimann K, Saremaslani P, Speel EJ, Heitz PU, Komminoth P. Am J Pathol; 1999 Feb 18; 154(2):429-36. PubMed ID: 10027401 [Abstract] [Full Text] [Related]
9. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas]. Gu LJ, Chen J, Liu TH, Cui QC, Lu ZH, Li L, Gao J. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr 18; 24(2):165-9. PubMed ID: 12905795 [Abstract] [Full Text] [Related]
10. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma. Kong XT, Choi SH, Inoue A, Xu F, Chen T, Takita J, Yokota J, Bessho F, Yanagisawa M, Hanada R, Yamamoto K, Hayashi Y. Cancer Res; 1997 Sep 01; 57(17):3772-8. PubMed ID: 9288786 [Abstract] [Full Text] [Related]
11. Analysis of the DPC4 gene in gastric carcinoma. Nishizuka S, Tamura G, Maesawa C, Sakata K, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R. Jpn J Cancer Res; 1997 Apr 01; 88(4):335-9. PubMed ID: 9197522 [Abstract] [Full Text] [Related]
13. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Lüttges J, Galehdari H, Bröcker V, Schwarte-Waldhoff I, Henne-Bruns D, Klöppel G, Schmiegel W, Hahn SA. Am J Pathol; 2001 May 01; 158(5):1677-83. PubMed ID: 11337365 [Abstract] [Full Text] [Related]
14. Dpc4 is expressed in virtually all primary and metastatic pancreatic endocrine carcinomas. Scarpa A, Orlandini S, Moore PS, Lemoine NR, Beghelli S, Baron A, Falconi M, Zamboni G. Virchows Arch; 2002 Feb 01; 440(2):155-159. PubMed ID: 11964045 [Abstract] [Full Text] [Related]
15. Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomas. Bartsch D, Barth P, Bastian D, Ramaswamy A, Gerdes B, Chaloupka B, Deiss Y, Simon B, Schudy A. Cancer Lett; 1999 May 03; 139(1):43-9. PubMed ID: 10408907 [Abstract] [Full Text] [Related]
16. [Detection of alterations of the DPC4 gene in paraffin-embedded tissues of pancreatic carcinomas]. Gu L, Cui Q, Chen J, Li L, Liu T. Zhonghua Bing Li Xue Za Zhi; 2000 Aug 03; 29(4):256-8. PubMed ID: 11866919 [Abstract] [Full Text] [Related]
17. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. Hua Z, Zhang YC, Hu XM, Jia ZG. World J Gastroenterol; 2003 Dec 03; 9(12):2764-7. PubMed ID: 14669329 [Abstract] [Full Text] [Related]
18. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation. Wilentz RE, Su GH, Dai JL, Sparks AB, Argani P, Sohn TA, Yeo CJ, Kern SE, Hruban RH. Am J Pathol; 2000 Jan 03; 156(1):37-43. PubMed ID: 10623651 [Abstract] [Full Text] [Related]
19. Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma. Moskaluk CA, Hruban RH, Schutte M, Lietman AS, Smyrk T, Fusaro L, Fusaro R, Lynch J, Yeo CJ, Jackson CE, Lynch HT, Kern SE. Diagn Mol Pathol; 1997 Apr 03; 6(2):85-90. PubMed ID: 9098646 [Abstract] [Full Text] [Related]
20. Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Iacobuzio-Donahue CA, Wilentz RE, Argani P, Yeo CJ, Cameron JL, Kern SE, Hruban RH. Am J Surg Pathol; 2000 Nov 03; 24(11):1544-8. PubMed ID: 11075857 [Abstract] [Full Text] [Related] Page: [Next] [New Search]